COCHLEAR FPO (ASX: COH) Share Price and News
Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
Cochlear Limited (COH) is a global leader in implantable hearing devices. The company manufactures and distributes cochlear implantable devices for hearing impaired.
Based in Sydney, Cochlear has operations in more than 20 countries, distributing its products in America, Asia Pacific, Europe, the Middle East and Africa. It offers three main products: Cochlear implants, Baha bone conduction implants and Cochlear Wireless Accessories.
Cochlear was formed in 1981, with COH shares first listing on the ASX almost 15 years later in 1995. Since then, the Cochlear share price has risen exponentially and the company is now one of the largest-listed companies on the ASX.
COCHLEAR FPO (ASX: COH) Latest News
James Mickleboro | November 28, 2019 12:33pm
CSL Limited (ASX:CSL) shares are one of three in the healthcare sector that I think investors should buy in 2020... More »
Kenneth Hall | November 28, 2019 9:59am
The Sigma Healthcare Ltd (ASX: SIG) has been a top performing stock on the ASX 200 November as its climbed 25% higher to $0.73... More »
Kenneth Hall | November 27, 2019 10:28am
The Aussie tech stocks have been among the winners this year, but could ASX healthcare outperform the WAAAX group in 2020? More »
Kenneth Hall | November 20, 2019 9:46am
The Cochlear Ltd (ASX: COH) share price has been rocketing higher for a number of years, but you may not have missed out on... More »
James Mickleboro | November 19, 2019 2:48pm
Altium Limited (ASX:ALU) shares are one of three that I would invest $10,000 into this week. Here's why I think they could be market... More »
Tom Richardson | November 19, 2019 11:59am
Sonic shares are up more than 10x since 1999 and you cannot beat the combination of rising dividends and share prices as an investor. More »
Kenneth Hall | October 31, 2019 1:06pm
The Nanosonics Ltd (ASX: NAN) share price has been a top performer on the ASX 200 this year - but will the momentum continue... More »